Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Eur J Pediatr ; 182(3): 1309-1315, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2174149

ABSTRACT

Most children with functional constipation (FC) improve with conventional treatments. However, a proportion of children have poor treatment outcomes. Management of intractable FC may include botulinum toxin injections, transanal irrigation, antegrade enemas, colonic resections, and in some cases sacral nerve stimulation (SNS). SNS is surgically placed, not readily available and expensive. Posterior tibial nerve stimulation (PTNS) allows transmission of electronic impulses and retrograde stimulation to the sacral nerve plexus in a portable, simple and non-invasive fashion. To assess the efficacy and safety of transcutaneous PTNS for the treatment of FC in children. Single-center, prospective interventional study. Children 4-14 years with Rome IV diagnosis of FC received ten daily PTNS (30 min/day) sessions. Electrodes placed over skin of ankle. Strength of stimulus was below pain threshold. Outcomes were assessed during treatment and 7 days after. Twenty-three subjects enrolled. Two children excluded (acute gastroenteritis, COVID-19 contact). Twenty completed the study (4-14 years), (8.4 ± 3.2 years, 71.4% female). We found significant improvement in the consistency of bowel movements (BM) (p = 0.005), fecal incontinence (FI) (p = 0.005), abdominal pain presence (p = < 0.001) and intensity (p = 0.005), and a significant for improvement in blood in stools (p = 0.037). There was 86.3% improvement in abdominal pain. 96.7% reported treatment satisfaction. Only one child required rescue therapy. CONCLUSION: We found significant improvement in stool consistency, FI, abdominal pain, and hematochezia. This suggests that transcutaneous PTNS could be a promising noninvasive treatment for FC in children. Large studies are needed. WHAT IS KNOWN: • Functional constipation is one of the most common disorders in children. • Current management of functional constipation consists of an integrative approach that includes medications, diet and behavioral strategies. WHAT IS NEW: • Posterior tibial nerve stimulation is a novel noninvasive and easy to use therapy that can improve stool consistency, fecal incontinence and blood in stools.


Subject(s)
COVID-19 , Fecal Incontinence , Transcutaneous Electric Nerve Stimulation , Child , Humans , Female , Male , Fecal Incontinence/therapy , Prospective Studies , Tibial Nerve/physiology , Treatment Outcome , Constipation/therapy , Abdominal Pain , Quality of Life
2.
Pediatr Surg Int ; 38(10): 1473-1479, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-2014131

ABSTRACT

PURPOSE: We sought to determine if children with functional constipation (FC) would have an improvement in bladder function with treatment of constipation with a bowel management program (BMP). METHODS: A single-institution review was performed in children aged 3-18 with FC who underwent a BMP from 2014 to 2020. Clinical characteristics, bowel management details, and the Vancouver Symptom Score for Dysfunctional Elimination Syndrome (VSS), Baylor Continence Scale (BCS), and Cleveland Clinic Constipation Score (CCCS) were collected. Data were analyzed using linear mixed effect modeling with random intercept. RESULTS: 241 patients were included with a median age of 9 years. Most were White 81 and 47% were female. Univariate tests showed improvement in VSS (- 3.6, P < 0.0001), BCS (- 11.96, P < 0.0001), and CCCS (- 1.9, P < 0.0001) among patients having undergone one BMP. Improvement was noted in VSS and CCCS among those with more than one BMP (VSS: - 1.66, P = 0.023; CCCS: - 2.69, P < 0.0001). Multivariate tests indicated undergoing a BMP does result in significant improvement in VSS, BCS, and CCCS (P < 0.0001). CONCLUSIONS: There is significant improvement in bladder function in children with FC who undergo a BMP. For patients with bowel and bladder dysfunction and FC, a BMP is a reasonable treatment strategy for lower urinary tract symptoms.


Subject(s)
Lower Urinary Tract Symptoms , Urinary Bladder , Child , Constipation/therapy , Female , Humans , Intestines , Male , Syndrome
3.
Clin J Oncol Nurs ; 25(6): 721-724, 2021 12 01.
Article in English | MEDLINE | ID: covidwho-1533299

ABSTRACT

Despite the high incidence of constipation in people with cancer, there is little research on management strategies for opioid-induced constipation (OIC). This project used the Plan-Do-Study-Act model to examine implementation of the Oncology Nursing Society GuidelinesTM to improve constipation management in patients with cancer. Nurse champions at four sites identified practice gaps, including providing education on OIC for patients who are new to opioids and increasing follow-up assessment. This project demonstrates that multisite, collaborative projects are feasible and may enhance patient quality of life and decrease anticipated complications.


Subject(s)
Neoplasms , Opioid-Induced Constipation , Analgesics, Opioid/adverse effects , Constipation/drug therapy , Constipation/therapy , Humans , Neoplasms/complications , Neoplasms/drug therapy , Quality of Life
5.
Medicina (Kaunas) ; 56(9)2020 Aug 27.
Article in English | MEDLINE | ID: covidwho-738923

ABSTRACT

The positive impact of probiotic strains on human health has become more evident than ever before. Often delivered through food, dietary products, supplements, and drugs, different legislations for safety and efficacy issues have been prepared. Furthermore, regulatory agencies have addressed various approaches toward these products, whether they authorize claims mentioning a disease's diagnosis, prevention, or treatment. Due to the diversity of bacteria and yeast strains, strict approaches have been designed to assess for side effects and post-market surveillance. One of the most essential delivery systems of probiotics is within food, due to the great beneficial health effects of this system compared to pharmaceutical products and also due to the increasing importance of food and nutrition. Modern lifestyle or various diseases lead to an imbalance of the intestinal flora. Nonetheless, as the amount of probiotic use needs accurate calculations, different factors should also be taken into consideration. One of the novelties of this review is the presentation of the beneficial effects of the administration of probiotics as a potential adjuvant therapy in COVID-19. Thus, this paper provides an integrative overview of different aspects of probiotics, from human health care applications to safety, quality, and control.


Subject(s)
Coronavirus Infections/prevention & control , Dietary Supplements/standards , Gastrointestinal Diseases/therapy , Liver Diseases/therapy , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Probiotics/therapeutic use , Betacoronavirus , COVID-19 , Celiac Disease/therapy , Clostridium Infections/therapy , Constipation/therapy , Coronavirus Infections/drug therapy , Coronavirus Infections/therapy , Depressive Disorder/therapy , Diverticular Diseases/therapy , Dysentery/therapy , Enterocolitis, Necrotizing/therapy , Fermented Foods , Food Hypersensitivity/therapy , Helicobacter Infections/therapy , Hepatic Encephalopathy/therapy , Humans , Inflammatory Bowel Diseases/therapy , Non-alcoholic Fatty Liver Disease/therapy , Pneumonia, Viral/therapy , Probiotics/adverse effects , Probiotics/standards , Quality Control , SARS-CoV-2 , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL